Manuscript Published On Multiorgan Failure Patients Treated With Seastar Medical'S Selective Cytopheretic Device Who Achieved Transplant Eligibility
SCDs ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical conditions published in Transpl
United States Jody Cain Eric Schrolff Drug Administration Seastar Medical Holding Corporation Nasdaq Clinical Development
Source: menafn.com